PRESS RELEASES

08-28-2012
Boulder, Colorado
Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Company's Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
    >>Click here for complete News Release

11-3-2010
Boulder, Colorado
Bolder BioTechnology Announces $1.2 Million in Qualifying Therapeutic Discovery Project Grants
    >>Click here for complete News Release

8-18-2010
Boulder, Colorado
Bolder BioTechnology Announces $600,000 Grant from NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome
    >>Click here for complete News Release

9-17-2009
Boulder, Colorado
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
    >>Click here for complete News Release

9-17-2009
Boulder, Colorado
Bolder BioTechnology Receives $1.2 Million from NIH to Study Long-Acting G-CSF and GM-CSF Analogs in Treating Acute Radiation Syndrome
    >>Click here for complete News Release

12-16-2008
Boulder, Colorado
Bolder BioTechnology Receives $1.9 million NIH Grant to Continue Development of Long-Acting Growth Hormone Product...
    >>Click here for complete News Release

10-15-2008
Boulder, Colorado
Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug...
    >>;Click here for complete News Release

View 2007 Archived Press Releases Here
View 2006 Archived Press Releases Here
View 2005 Archived Press Releases Here
View 2004 Archived Press Releases Here
View 2003 Archived Press Releases Here
View 2002 Archived Press Releases Here